<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang Y</submitter><funding>HKU State Key Laboratory of Pharmaceutical Biotechnology</funding><funding>HKU</funding><funding>Science and Technology Foundation of Guangdong Province</funding><funding>National Natural Science Foundation of China</funding><funding>Theme-based Research Scheme</funding><pagination>749-763</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5063626</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(4)</volume><pubmed_abstract>Mesenchymal stem cells (MSCs) can donate mitochondria and rescue anthracycline-induced cardiomyocyte (CM) damage, although the underlying mechanisms remain elusive. We determined that the superior efficiency of mitochondrial transfer by human induced-pluripotent-stem-cell-derived MSCs (iPSC-MSCs) compared with bone marrow-derived MSCs (BM-MSCs) is due to high expression of intrinsic Rho GTPase 1 (MIRO1). Further, due to a higher level of TNFαIP2 expression, iPSC-MSCs are more responsive to tumor necrosis factor alpha (TNF-α)-induced tunneling nanotube (TNT) formation for mitochondrial transfer to CMs, which is regulated via the TNF-α/NF-κB/TNFαIP2 signaling pathway. Inhibition of TNFαIP2 or MIRO1 in iPSC-MSCs reduced the efficiency of mitochondrial transfer and decreased CMs protection. Co</pubmed_abstract><journal>Stem cell reports</journal><pubmed_title>iPSC-MSCs with High Intrinsic MIRO1 and Sensitivity to TNF-α Yield Efficacious Mitochondrial Transfer to Rescue Anthracycline-Induced Cardiomyopathy.</pubmed_title><pmcid>PMC5063626</pmcid><funding_grant_id>31270967</funding_grant_id><funding_grant_id>201007176100</funding_grant_id><funding_grant_id>T12-705/11</funding_grant_id><funding_grant_id>31571407</funding_grant_id><funding_grant_id>201409176221</funding_grant_id><funding_grant_id>2015B020225001</funding_grant_id><pubmed_authors>Chai YH</pubmed_authors><pubmed_authors>Tse HF</pubmed_authors><pubmed_authors>Chow Y</pubmed_authors><pubmed_authors>Liang X</pubmed_authors><pubmed_authors>Liang Y</pubmed_authors><pubmed_authors>Han S</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Xu A</pubmed_authors><pubmed_authors>Jiang D</pubmed_authors><pubmed_authors>Liao S</pubmed_authors><pubmed_authors>Yu Z</pubmed_authors><pubmed_authors>Yue W</pubmed_authors><pubmed_authors>Lian Q</pubmed_authors><pubmed_authors>Chiu SM</pubmed_authors></additional><is_claimable>false</is_claimable><name>iPSC-MSCs with High Intrinsic MIRO1 and Sensitivity to TNF-α Yield Efficacious Mitochondrial Transfer to Rescue Anthracycline-Induced Cardiomyopathy.</name><description>Mesenchymal stem cells (MSCs) can donate mitochondria and rescue anthracycline-induced cardiomyocyte (CM) damage, although the underlying mechanisms remain elusive. We determined that the superior efficiency of mitochondrial transfer by human induced-pluripotent-stem-cell-derived MSCs (iPSC-MSCs) compared with bone marrow-derived MSCs (BM-MSCs) is due to high expression of intrinsic Rho GTPase 1 (MIRO1). Further, due to a higher level of TNFαIP2 expression, iPSC-MSCs are more responsive to tumor necrosis factor alpha (TNF-α)-induced tunneling nanotube (TNT) formation for mitochondrial transfer to CMs, which is regulated via the TNF-α/NF-κB/TNFαIP2 signaling pathway. Inhibition of TNFαIP2 or MIRO1 in iPSC-MSCs reduced the efficiency of mitochondrial transfer and decreased CMs protection. Co</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Oct</publication><modification>2026-05-05T05:44:40.11Z</modification><creation>2026-04-07T21:30:53.004Z</creation></dates><accession>S-EPMC5063626</accession><cross_references><pubmed>27641650</pubmed><doi>10.1016/j.stemcr.2016.08.009</doi></cross_references></HashMap>